The Benjamin Pool Playbook: Real Levels, No Fluff
If you feel like you’re always "buying the top" or "selling the bottom," it’s likely because you’re zuma following the headlines instead of the price action. In this video, I’m taking you inside my personal charts to show you the exact levels I’m watching for SMR, OKLO, NNE, and NVS. We are looking for high-probability bounces in the nuclear sector and a strategic "top-out" play in pharma.
I’m Benjamin Pool. When I’m not hosting Today's Best Trade Setups over at Verified Investing (catch me there every weekday at 8:45 AM ET!), I’m here on my personal channel sharing the raw setups that catch my eye. Whether you are a beginner or a seasoned trader, these "lines in the sand" are designed to help you manage risk first and chase profits second.
Nuclear Energy: Buying the 75% Discount (SMR, OKLO, NNE)
The nuclear energy sector has been aggressive, but we are currently seeing a massive reset. These are speculative plays—they aren't all profitable yet—but the technical support levels don't lie.
SMR (NuScale Power): The "Gallon of Milk" Analogy SMR is getting beaten up. We tried to clear $23, got rejected, and broke the $16.91 support. My first aggressive level is $13.64, but for those who want a safer entry, look at $11.21. This is a major pivot from a year ago. Think of it like a gallon of milk: it was $12, now it’s getting back to $4. That is where the value lives.
OKLO Inc: The Institutional Anchor at $60.54 OKLO is in a clear downtrend, but it's approaching a level where both retail and institutions are likely to step in. I’m tracking the $60.54 support. If we close below that on a daily basis, the next "shelf" is all the way down at $38.09. I’m being patient here—I want to see the downward trendline break before I put my capital at risk.
NNE (Nano Nuclear): The RSI 22 Strategy NNE is down 7 days in a row. Most beginners want to buy because it's "cheap," but I wait for RSI exhaustion. We just hit 30, but I’m looking for rae $17.21, which aligns with an RSI of 22. This is a speculative play, so I plan to Dollar Cost Average (DCA) every 10% lower to "load the boat" for the eventual 15% bounce.
Novartis (NVS): The "Rising Wedge" Short Setup
While the nuclear plays are hitting a floor, Novartis (NVS) looks like it's hitting a ceiling. It’s overextended and sitting at the top of a wedge pattern.
The NVS Strategy: We’ve seen three hits on the upper trendline near $140. In my playbook, the third hit is often the top. I’m looking for a short entry around $138-$140 with an initial take-profit at $129. If the selling accelerates, we could see $120.95. The beauty of this trade? I’m risking roughly $2 to potentially make $20. If it closes above $140.32, I’m out—simple as that.
Today’s Key "Lines in the Sand"
SMR: Aggressive Support: $13.64 | Deep Value Floor: $11.21.
OKLO: The $60.54 Pivot | Secondary Support: $38.09.
NNE: Target Entry: $17.21 | RSI Target: 22.
NVS: Short Entry: $138-$140 | Target 1: $129 | Target 2: $120.
Level Up Your Trading Every Morning
If you want to transition from "guessing" to "calculating," you need a morning routine. Join me every weekday at 8:45 AM ET for Today's tomas hertl Best Trade Setups on the Verified Investing YouTube channel. We spend 15 minutes before the bell mapping out the S&P 500, the Nasdaq, and the top movers so you can start your day with a professional roadmap.
#benjaminpool #smr #oklo #nvs #technicalanalysis #verifiedinvesting
